title: [Emergent viruses: SARS-associate coronavirus and H5N1 influenza virus].
abstract: Two viral agents with RNA genome are responsible for emerging illnesses: influenza virus A/H5N1 and Severe Acute Respiratory Syndrome virus (SARS). For the diagnosis of SARS virus infection, an epidemiological investigation is necessary to know whether the patient has been exposed to a risk in a country where the SARS virus is circulating or whether the patient had worked in a laboratory handling SARS virus. The detection of SARS virus is possible in various clinical samples (including urine) by viral culture or RT-PCR. The handling of those samples and RNA extraction must be performed in a BSL3 laboratory. The SARS virus RT-PCR is poorly sensitive, therefore the test should be performed on samples collected consecutively for several days. In front of a suspicion of A/H5N1, similar procedures are recommended. An epidemiologic investigation is necessary to specify whether the patient stayed in a country where A/H5N1 virus was circulating. Clinical samples needed for a specific diagnosis are: nasopharyngeal, throat-swab or fecal samples, cerebrospinal fluid and blood. The presence of A/H5N1 virus is confirmed by viral isolation or RNA detection by RT-PCR. RNA extraction must be performed in a BSL3 laboratory. For diagnosis of A/H5N1 virus infection, RT-PCR test amplifies specifically a fragment of H5 gene (Hemagglutinin). In french laboratories of medical virology, procedures are ready to diagnose the first case of A/H5N1 virus infection and cases of reemerging SARS virus infection.
authors.affiliation: Service de virologie, UPRES-EA3610, CHRU Lille, Faculté de Médecine, Université Lille 2, Bâtiment P. Boulanger, Lille.
authors.forename: A
authors.initials: A
authors.lastname: Goffard
authors.forename: M
authors.initials: M
authors.lastname: Lazrek
authors.forename: C
authors.initials: C
authors.lastname: Schanen
authors.forename: P-E
authors.initials: PE
authors.lastname: Lobert
authors.forename: L
authors.initials: L
authors.lastname: Bocket
authors.forename: A
authors.initials: A
authors.lastname: Dewilde
authors.forename: D
authors.initials: D
authors.lastname: Hober
mesh_terms: D021821:Communicable Diseases, Emerging; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000472:pathogenicity*; D007251:Influenza, Human / Q000175:diagnosis / Q000453:epidemiology; D045473:Severe acute respiratory syndrome-related coronavirus / Q000472:pathogenicity*; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000453:epidemiology